Dizziness Due to Visual Stimuli in Patients with Concussion and Other Causes of Dizziness: Examination of Balance Behaviour
Launched by DOMINIK STRAUMANN · Mar 17, 2025
Trial Information
Current as of April 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain visual patterns can affect balance in people who experience dizziness, especially those who have had a concussion or other causes of dizziness. The researchers want to see how different types of visual stimulation, like moving patterns shown on a rotating disk or through a virtual reality headset, impact the balance of patients compared to healthy individuals. By observing how these visual effects make people feel—like if they experience dizziness, headaches, or nausea—the study hopes to better understand a condition called visually induced dizziness (VID) and improve how it is diagnosed and treated.
To participate in this study, you need to be between 18 and 60 years old and have had a recent concussion or dizziness symptoms. The researchers will only include those who have binocular vision (meaning you can use both eyes together) and have been experiencing symptoms within a specific time frame. Participants will undergo balance assessments while viewing the visual patterns, and they will be monitored for any symptoms they experience. This innovative approach aims to provide more accurate results that could help doctors better manage and treat patients with VID in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 60 years
- • Binocular vision
- • Recent concussion/mTBI within 4 weeks to 18 months post-injury for concussed patients
- • Diagnosis related to dizziness or VID within 4 weeks to 18 months for non-concussed dizzy patients (including vestibular migraine)
- • Signed ICF for included participants or signed general consent for retrospectively included patients if an ICF cannot be obtained.
- Exclusion Criteria:
- • BMI greater than 30
- • Acute vestibular syndrome lasting at least 24 hours
- • Severe non-correctable visual impairment
- * Balance issues not dizziness-related, including:
- • 1. Neurological conditions (e.g., migraine)
- • 2. Orthopaedic conditions (e.g., lower extremity injury)
- • 3. Infectious diseases
- • 4. Other medical contexts
- • Dizziness attributed to prescribed drugs, substance abuse, or mental disorders
- • Cognitive impairments compromising task comprehension
- • Preceding history of traumatic brain injury in the last 12 months
- • History of severe traumatic brain injury with persisting impairments
- • Other potentially confounding problems (e.g., psychiatric disease)
- • Frequent episodes of rotatory vertigo
About Dominik Straumann
Dominik Straumann is a dedicated clinical trial sponsor focused on advancing medical research and innovation in the healthcare sector. With a commitment to enhancing patient outcomes, the organization collaborates with leading researchers and institutions to design and implement rigorous clinical studies. Dominik Straumann prioritizes ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost integrity and transparency. Through its strategic partnerships and a patient-centered approach, the sponsor aims to contribute significantly to the development of novel therapies and improve the overall quality of care in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, Zh, Switzerland
Zurich, Zh, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported